NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $38,187 | -63.9% | 2,364,459 | -7.1% | 0.01% | -60.0% |
Q2 2023 | $105,638 | -33.9% | 2,545,465 | -4.2% | 0.02% | -37.5% |
Q1 2023 | $159,714 | +0.4% | 2,655,686 | +22.5% | 0.02% | -7.7% |
Q4 2022 | $159,054 | -99.9% | 2,168,431 | -8.6% | 0.03% | -13.3% |
Q3 2022 | $180,225,000 | +11.2% | 2,371,986 | +1.7% | 0.03% | +50.0% |
Q2 2022 | $162,030,000 | -7.5% | 2,331,367 | +10.3% | 0.02% | +11.1% |
Q1 2022 | $175,075,000 | +56.9% | 2,113,151 | +42.2% | 0.02% | +80.0% |
Q4 2021 | $111,581,000 | -32.9% | 1,486,168 | +3.7% | 0.01% | -37.5% |
Q3 2021 | $166,410,000 | -52.2% | 1,432,467 | -8.7% | 0.02% | -50.0% |
Q2 2021 | $348,143,000 | +114.5% | 1,569,485 | +27.8% | 0.03% | +100.0% |
Q1 2021 | $162,278,000 | -24.3% | 1,227,702 | -0.8% | 0.02% | -27.3% |
Q4 2020 | $214,259,000 | +58.4% | 1,238,204 | +1.9% | 0.02% | +37.5% |
Q3 2020 | $135,277,000 | +93.1% | 1,215,318 | +2.9% | 0.02% | +77.8% |
Q2 2020 | $70,049,000 | -16.8% | 1,181,267 | -5.6% | 0.01% | -30.8% |
Q1 2020 | $84,243,000 | -24.9% | 1,251,011 | -6.0% | 0.01% | -13.3% |
Q4 2019 | $112,133,000 | -5.6% | 1,330,637 | -16.2% | 0.02% | -11.8% |
Q3 2019 | $118,738,000 | -20.3% | 1,587,837 | -32.6% | 0.02% | -19.0% |
Q2 2019 | $149,064,000 | +59.8% | 2,357,482 | +21.8% | 0.02% | +50.0% |
Q1 2019 | $93,269,000 | +44.6% | 1,936,247 | +0.5% | 0.01% | +27.3% |
Q4 2018 | $64,502,000 | -40.1% | 1,926,579 | -6.3% | 0.01% | -31.2% |
Q3 2018 | $107,689,000 | +404.8% | 2,055,136 | +201.6% | 0.02% | +433.3% |
Q2 2018 | $21,332,000 | -29.2% | 681,519 | -73.6% | 0.00% | -50.0% |
Q2 2016 | $30,116,000 | -19.6% | 2,580,593 | -0.3% | 0.01% | -25.0% |
Q1 2016 | $37,481,000 | -32.7% | 2,588,465 | -0.0% | 0.01% | -33.3% |
Q4 2015 | $55,730,000 | – | 2,588,825 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |